Home/Filings/4/0000950170-24-007642
4//SEC Filing

YOUNGBLOOD DR KNEELAND 4

Accession 0000950170-24-007642

CIK 0001839341other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 9:05 PM ET

Size

7.8 KB

Accession

0000950170-24-007642

Insider Transaction Report

Form 4
Period: 2024-01-23
Transactions
  • Disposition to Issuer

    Common Stock, par value $0.0001 per share

    2024-01-23400,0380 total
  • Award

    Common Stock, par value $0.00001 per share

    2024-01-23+400,038400,038 total
Footnotes (2)
  • [F1]On December 21, 2022, Core Scientific, Inc. (the "Issuer") and certain of its affiliates (collectively, the "Debtors") filed voluntary petitions (the "Chapter 11 Cases") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court") seeking relief under Chapter 11 of Title 11 of the United States Code. On January 16, 2024, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) (the "Plan"), dated as of January 15, 2024. On January 23, 2024 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.
  • [F2]On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock received their pro rata share of new common stock, par value $0.00001 per share ("New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization). The receipt of the New Common Stock in exchange for Old Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court.

Documents

1 file

Issuer

Core Scientific, Inc./tx

CIK 0001839341

Entity typeother

Related Parties

1
  • filerCIK 0001137820

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 9:05 PM ET
Size
7.8 KB